A pinch of salt - A podcast by ERA cover art

All Episodes

A pinch of salt - A podcast by ERA — 136 episodes

#
Title
1

#81 Diuretics in Acute Heart Failure: take them with a “pinch of salt”? with Jozene Ter Maaten

2

#80 European Specialty Examination in Nephrology: demystifying the ESENeph with David Lappin

3

#79 Osteoporosis in CKD: when bone and kidneys disagree? with Hanne Skou Jørgensen

4

Trailer Osteoporosis in CKD: when bone and kidneys disagree?, European Specialty Examination in Nephrology: demystifying the ESENeph and Diuretics in Acute Heart Failure: take them with a “pinch of salt”?

5

#78 B-cell therapy in IgA Nephropathy: worth the hype? with Vlado Perkovic

6

#77 Generative AI for the busy nephrologist: adapt or perish? with Wisit Cheungpasitporn

7

#76 Late Breakers, LIVE from Glasgow, with Alberto Ortiz and Danilo Fliser

8

Trailer Late Breakers, LIVE from Glasgow, Generative AI for the busy nephrologist: adapt or perish? and B-cell therapy in IgA Nephropathy: worth the hype?

9

#75 What is narrative-based medicine? with Amy Waterman

10

#74 Inflammation and Aging in CKD – From Translational Basics to Clinical Practice, with Peter Stenvinkel

11

#73 Inhibition of Aldosterone Synthase and MRAs in Nephrology, with Maria Jose Soler Romeo

12

Trailer Inhibition of Aldosterone Synthase and MRAs in Nephrology, Inflammation and Aging in CKD – From Translational Basics to Clinical Practice, What is narrative-based medicine?

13

#72 Liquid Biopsies and Other AI Goodies in Nephrology, with Valentin Goutaudier

14

#71 Obstacles for the Development of Peritoneal Dialysis – A Solution Toolbox, with Karlien François

15

#70 How to tackle PD complications? with Sana F. Khan

16

Trailer How to tackle PD complications?, Obstacles for the Development of Peritoneal Dialysis – A Solution Toolbox and Liquid Biopsies and Other AI Goodies in Nephrology

17

#69 A Practical Guide on Frailty and Sarcopenia for CKD Patients, with Thomas Wilkinson

18

#68 What’s New in Vascular Access? With Tamara Jemcov

19

#67 Extracorporeal Adsorption Techniques in ICU Patients – When to Say Yes, When to Suggest No? With Thomas Rimmele

20

Trailer Extracorporeal adsorption techniques in ICU patients – when to say yes, when to suggest no?, What's new in vascular access?, A Practical Guide on Frailty and Sarcopenia for CKD Patients

21

#66 Patient-reported outcomes in clinical practice, with Paul Cockwell

22

#65 About the GFR formulas – How to measure renal function in 2026? with Pierre Delanaye

23

#64 Evolution of Treatment Paradigms in ANCA Vasculitis, with David Jayne

24

Trailer Evolution of Treatment Paradigms in ANCA Vasculitis, About the GFR formulas – How to measure renal function in 2026? and Patient-reported outcomes in clinical practice

25

#63 Treatment of obesity in patients with CKD, with Allon N. Friedman

26

#62 Chronic kidney disease of unknown etiology, with Shuchi Anand

27

#61 Tubulointerstitial nephritis – the Cinderella of nephrology, with Beatriz Sanchez Alamo

28

Trailer Tubulointerstitial nephritis – the Cinderella of nephrology, Chronic kidney disease of unknown etiology, Treatment of obesity in patients with CKD

29

#60 Most common mistakes in biostatistics, with Giovanni Tripepi

30

#59 Cryoglobulinemia, with Luca Quartuccio

31

#58 BK nephropathy, with Camille Kotton

32

Trailer BK nephropathy, Cryoglobulinemia and Most common mistakes in biostatistics

33

#57 Presentation of the «Strong Kidneys Task Force», with Charles Ferro

34

#56 Hepatorenal syndrome, with Juan Carlos Q. Velez

35

#55 Diet and hyperkalemia, with Alice Sabatino

36

Trailer Presentation of the «Strong Kidneys Task Force», Diet and hyperkalemia and Hepatorenal syndrome

37

#54 Sustainable nephrology, with Ivo Laranjinha and Susi Knöller

38

#53 Antibody-mediated rejection treatment – now and in the future, with Georg Böhmig

39

#52 Primary hyperoxaluria type 1, with Justine Bacchetta

40

Trailer Primary hyperoxaluria type 1, Antibody-mediated rejection treatment – now and in the future and Sustainable nephrology

41

#51 Monoclonal gammopathy with renal significance, with Jolanta Małyszko

42

#50 Onconephrology: A huge subject, with Kenar D. Jhaveri

43

#49 Obesity and CKD, with Marieta Theodorakopoulou

44

Trailer Obesity and CKD, Onconephrology: A huge subject and Monoclonal gammopathy with renal significance

45

#48 Xenotransplantation: Is it for real? with David Cooper

46

#47 Infection prophylaxis for renal transplant recipients in 2025, with Ilaria Gandolfini

47

#46 Adapting anti-rejection treatment in a failing renal graft, with Cristophe Mariat

48

Trailer Adapting anti-rejection treatment in a failing renal graft, Infection prophylaxis for renal transplant recipients in 2025 and Xenotransplantation: Is it for real?

49

#45 Atypical HUS, with Neil Sheerin

50

#44 C3 glomerulopathy, with Marina Vivarelli

51

#43 IgG4-related disease, with John Stone

52

Trailer IgG4-related disease, C3 glomerulonephritis and Atypical HUS

53

#42 A patient's view of nephrology, with Malene Deele

54

#41 How to anticoagulate CKD patients with Atrial Fibrilation?, with Frida Welander

55

#40 Avacopan in ANCA-Associated Vasculitis, with Lorraine Harper

56

Trailer A patient's view of nephrology

57

Trailer How to anticoagulate CKD patients with Atrial Fibrilation?

58

Trailer Avacopan in ANCA-Associated Vasculitis

59

#39 Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease, with Adeera Levin

60

#38 Approach to conservative care, with Holly Koncicki

61

#37 A nurse’s view of nephrology, with Jeanette Finderup

62

Trailer Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease

63

Trailer Approach to conservative care

64

Trailer A nurse’s view of nephrology

65

#36 Imlifidase – a new tool in transplantation, with Rainer Oberbauer

66

#35 ANCA vasculitis – novelties and difficult cases, with Vladimir Tesar

67

#34 The treatment of arterial hypertension in 2025, with Pantelis Sarafidis

68

Trailer Imlifidase – a new tool in transplantation

69

Trailer ANCA vasculitis – novelties and difficult cases

70

Trailer The treatment of arterial hypertension in 2025

71

#33 What vaccines should I perform to my CKD patients? With Nina Babel

72

#32 A renal pathologist in 2024 in plain English, with Ingeborg Bajema

73

#31 Research and publishing tips for the uninitiated, with Andreas Kronbichler

74

Trailer What vaccines should I perform to my CKD patients?

75

Trailer A renal pathologist in 2024 in plain English

76

Trailer Research and publishing tips for the uninitiated

77

#30 Up to date on ADPKD, with Roman Ulrich-Müller

78

#29 Understanding genetics in nephrology, with Emilie Cornec-Le Gall

79

#28 Transition from paediatric to adult nephrological care, with Arvind Nagra

80

Trailer Up to date on ADPKD

81

Trailer Understanding genetics in nephrology

82

Trailer Transition from paediatric to adult nephrological care

83

#27 Pregnancy and kidney disease, with Matthew Hall

84

#26 How to prepare for disaster nephrology? With Serhan Tuglular

85

#25 Vascular calcifications and Calciphylaxis, with Smeeta Sinha

86

Trailer Pregnancy and kidney disease

87

Trailer How to prepare for disaster nephrology?

88

Trailer Vascular calcifications and Calciphylaxis

89

#24 Social media in nephrology - a crash course, with Samira Farouk

90

#23 The CKD-MBD treatment conundrum, with Mathias Haarhaus

91

#22 Registering the register. A view of the renal register's activities, with Alberto Ortiz

92

Trailer Social media in nephrology - a crash course

93

Trailer The CKD-MBD treatment conundrum

94

Trailer Registering the register. A view of the renal register's activities

95

#21 Why do we need YNP? With Orsolya Cseprekál

96

#20 Sleep disorders in CKD, with Mark Unruh

97

#19 Cardiorenal syndrome for the confused nephrology interns, with Patrick Mark

98

Trailer Why do we need YNP?

99

Trailer Sleep disorders in CKD

100

Trailer Cardiorenal syndrome for the confused nephrology interns

101

#18 DKK3 - finally a biomarker of ongoing kidney injury, with Danilo Fliser

102

#17 Pearls on research and publishing from the editors of NDT and CKJ, with Hans-Joachim Anders and Jürgen Floege

103

#16 AI in nephrology, with Roser Torra

104

Trailer DKK3 - finally a biomarker of ongoing kidney injury

105

Trailer Pearls on research and publishing from the editors of NDT and CKJ

106

Trailer AI in nephrology

107

#15 IgA nephropathy, with Jonathan Barratt

108

#14 CKD-associated pruritus, with Antoine Lanot

109

#13 Proteinuria - the common suspect, with Annette Bruchfeld

110

Trailer IgA nephropathy

111

Trailer CKD-associated pruritus

112

Trailer Proteinuria

113

#12 SGLT2i / MRAs / GLP1s, with Katherine Tuttle

114

#11 How to start a career in dialysis access, with Jernej Pajek

115

#10 Intradialytic hypotension, with Andrew Davenport

116

Trailer SGLT2i / MRAs / GLP1s

117

Trailer How to start a career in dialysis access

118

Trailer Intradialytic hypotension

119

#9 Physical activity in CKD, with Alice Smith

120

#8 Management of CKD in older people, with Elke Schäffner

121

#7 Protein energy wasting in CKD, with Giorgina Piccoli

122

Trailer Physical activity in CKD

123

Trailer Management of CKD in older people

124

Trailer Protein energy wasting in CKD

125

#6 - Immune checkpoint inhibitors, with Sandra Herrmann

126

#5 - Diabetic Nephropathy, with Enrique Morales

127

#4 - Kidney stones, with David Goldfarb

128

Trailer Immune checkpoint inhibitors

129

Trailer Diabetic Nephropathy

130

Trailer Kidney stones

131

#3 - How to start PD as a doctor, as a patient with Joanne Bargman

132

#2 - Being ERA president with Christoph Wanner

133

#1 - Contrast associated AKI with Swapnil Hiremath

134

Trailer How to start PD

135

Trailer Being ERA President

136

Trailer Contrast associated AKI